The LMB’s longstanding record of excellence and innovation has largely been achieved by a strategy of attracting and retaining outstanding scientists. Whilst working at the Laboratory they have the freedom and resources to pursue the opportunities they recognise as being fundamentally important to their area of molecular science.
Over the last 50 years the LMB’s researchers have made countless discoveries that have had tangible benefits for the health of millions of people in the UK and worldwide, from the sequencing of DNA to the development of humanised monoclonal antibodies that are now used to treat a range of chronic diseases.
LMB scientists have generated over £330 million through technology transfer – providing valuable additional income to help support UK science.
In addition the LMB supports the wider scientific community by supplying highly trained leaders in academic research. They leave the LMB to develop and support molecular science in the UK and around the world.
Therapeutic antibodies and the LMB
Find out about the key contribution made by LMB scientists in the development of therapeutic antibodies, in translating their work to the clinic and in founding three UK biotechnology companies. More…